| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Özge Türkoğlu, Aygün Ertuğru. The Role of Cannabis in the Development of Psychosis. Turk psikiyatri dergisi = Turkish journal of psychiatry. vol 35. issue 3. 2024-09-03. PMID:39224996. |
studies showed that the endocannabinoid system, which plays a role in nervous system development and functions as a homeostatic regulator in physiological processes, is affected by cannabis use during critical periods of development like adolescence; cannabis use affects physiological processes such as synaptic pruning due to the effects of this system on neurotransmitters like glutamate and dopamine leading to long-term behavioral and psychological consequences. |
2024-09-03 |
2024-09-05 |
Not clear |
| Macarena González-Portilla, Sandra Montagud-Romero, Susana Mellado, Fernando Rodríguez de Fonseca, María Pascual, Marta Rodríguez-Aria. Region-Specific Gene Expression Changes Associated with Oleoylethanolamide-Induced Attenuation of Alcohol Self-Administration. International journal of molecular sciences. vol 25. issue 16. 2024-08-29. PMID:39201687. |
biochemical analyses showed that oea induced gene expression changes in dopamine and cannabinoid receptors in the striatum and hippocampus. |
2024-08-29 |
2024-09-04 |
Not clear |
| Martina Di Bartolomeo, Andrea Čerňanová, Veronika Petrušová, Serena Di Martino, Július Hodosy, Filippo Drago, Vincenzo Micale, Claudio D'Addari. DNA methylation at cannabinoid type 1 and dopamine D2 receptor genes in saliva samples of psychotic subjects: is there an effect of Cannabis use? Pharmacological research. 2024-08-10. PMID:39127265. |
dna methylation at cannabinoid type 1 and dopamine d2 receptor genes in saliva samples of psychotic subjects: is there an effect of cannabis use? |
2024-08-10 |
2024-08-13 |
human |
| Martina Di Bartolomeo, Andrea Čerňanová, Veronika Petrušová, Serena Di Martino, Július Hodosy, Filippo Drago, Vincenzo Micale, Claudio D'Addari. DNA methylation at cannabinoid type 1 and dopamine D2 receptor genes in saliva samples of psychotic subjects: is there an effect of Cannabis use? Pharmacological research. 2024-08-10. PMID:39127265. |
according to the well-documented dysregulation ofendocannabinoid and dopaminergic system genes in schizophrenia, we investigated dna methylation cannabinoid type 1 receptor (cnr1) and dopamine d2 receptor (drd2) genes in saliva samples from psychotic subjects using pyrosequencing. |
2024-08-10 |
2024-08-13 |
human |
| Jessica L Maples-Keller, Laura Watkins, Natalie Hellman, Nathaniel L Phillips, Barbara O Rothbau. Treatment Approaches for Posttraumatic Stress Disorder Derived from Basic Research on Fear Extinction. Biological psychiatry. 2024-07-20. PMID:39032727. |
pharmacological, behavioral, and device-based augmentation strategies of ptsd treatment based in basic science findings are reviewed, including those that disrupt noradrenergic receptor processes, medications that act on nmda receptors, physical exercise, cannabinoids, estradiol, dexamethasone, yohimbine, losartan, dopamine, and mdma, along with the evidence for their efficacy in human clinical samples. |
2024-07-20 |
2024-07-24 |
human |
| Man Liu, Dong Pan, MengYa Wang, Han Deng, ZeGang M. JWH133 attenuates behavior deficits and iron accumulation in the 6-OHDA-induced Parkinson's disease model rats. Journal of neurophysiology. 2024-07-17. PMID:39015077. |
growing evidence indicated that activation of cannabinoid type 2 (cb2) receptors protect dopamine neurons in the pathogenesis of parkinson's disease (pd). |
2024-07-17 |
2024-07-19 |
rat |
| Kevin M Honeywell, Timothy G Freels, Megan A McWain, Abigail S Chaffin, Hunter G Nolen, Helen J Sable, Deranda B Leste. Indirect and direct cannabinoid agonists differentially affect mesolimbic dopamine release and related behaviors. Behavioral neuroscience. vol 138. issue 2. 2024-04-25. PMID:38661670. |
the present study examined the effect of indirect and direct cannabinoid agonists on mesolimbic dopamine release and related behaviors in c57bl/6j (b6) mice. |
2024-04-25 |
2024-04-28 |
mouse |
| Maysam Fadaei-Kenarsary, Khadijeh Esmaeilpour, Mohammad Shabani, Vahid Sheiban. Maternal Substance Use and Early-Life Adversity: Inducing Drug Dependence in Offspring, Interactions, Mechanisms, and Treatments. Addiction & health. vol 16. issue 1. 2024-04-23. PMID:38651025. |
treatments include antidepressants, histone deacetylase inhibitors, lamotrigine, ketamine, choline, modafinil, methadone, dopamine, cannabinoid 1 receptor agonists/antagonists, vitamins, oxytocin, tetrahydrocannabinol, sr141716a, and dronabinol. |
2024-04-23 |
2024-04-26 |
Not clear |
| C Medina-Saldivar, G V E Pardo, L F Pacheco-Otalor. Effect of MCH1, a fatty-acid amide hydrolase inhibitor, on the depressive-like behavior and gene expression of endocannabinoid and dopaminergic-signaling system in the mouse nucleus accumbens. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas. vol 57. 2024-02-21. PMID:38381881. |
this inhibition can modulate endocannabinoid and dopamine signaling in the nucleus accumbens (nac), potentially having an antidepressant-like effect. |
2024-02-21 |
2024-02-24 |
mouse |
| Miguel Á Luján, Dan P Covey, Reana Young-Morrison, LanYuan Zhang, Andrew Kim, Fiorella Morgado, Sachin Patel, Caroline E Bass, Carlos Paladini, Joseph F Chee. Mobilization of endocannabinoids by midbrain dopamine neurons is required for the encoding of reward prediction. Nature communications. vol 14. issue 1. 2023-11-24. PMID:37985770. |
brain levels of the endocannabinoid 2-arachidonoylglycerol (2-ag) shape motivated behavior and nucleus accumbens (nac) dopamine release. |
2023-11-24 |
2023-11-28 |
mouse |
| Weihua Ding, Liuyue Yang, Eleanor Shi, Bowon Kim, Sarah Low, Kun Hu, Lei Gao, Ping Chen, Wei Ding, David Borsook, Andrew Luo, Jee Hyun Choi, Changning Wang, Oluwaseun Akeju, Jun Yang, Chongzhao Ran, Kristin L Schreiber, Jianren Mao, Qian Chen, Guoping Feng, Shiqian She. Author Correction: The endocannabinoid N-arachidonoyl dopamine is critical for hyperalgesia induced by chronic sleep disruption. Nature communications. vol 14. issue 1. 2023-11-13. PMID:37957140. |
author correction: the endocannabinoid n-arachidonoyl dopamine is critical for hyperalgesia induced by chronic sleep disruption. |
2023-11-13 |
2023-11-20 |
Not clear |
| Weihua Ding, Liuyue Yang, Eleanor Shi, Bowon Kim, Sarah Low, Kun Hu, Lei Gao, Ping Chen, Wei Ding, David Borsook, Andrew Luo, Jee Hyun Choi, Changning Wang, Oluwaseun Akeju, Jun Yang, Chongzhao Ran, Kristin L Schreiber, Jianren Mao, Qian Chen, Guoping Feng, Shiqian She. The endocannabinoid N-arachidonoyl dopamine is critical for hyperalgesia induced by chronic sleep disruption. Nature communications. vol 14. issue 1. 2023-10-25. PMID:37880241. |
the endocannabinoid n-arachidonoyl dopamine is critical for hyperalgesia induced by chronic sleep disruption. |
2023-10-25 |
2023-11-08 |
mouse |
| Weihua Ding, Liuyue Yang, Eleanor Shi, Bowon Kim, Sarah Low, Kun Hu, Lei Gao, Ping Chen, Wei Ding, David Borsook, Andrew Luo, Jee Hyun Choi, Changning Wang, Oluwaseun Akeju, Jun Yang, Chongzhao Ran, Kristin L Schreiber, Jianren Mao, Qian Chen, Guoping Feng, Shiqian She. The endocannabinoid N-arachidonoyl dopamine is critical for hyperalgesia induced by chronic sleep disruption. Nature communications. vol 14. issue 1. 2023-10-25. PMID:37880241. |
metabolomics revealed that the level of n-arachidonoyl dopamine (nada), an endocannabinoid, was decreased in the trn after csd. |
2023-10-25 |
2023-11-08 |
mouse |
| Lisa Bornscheuer, Andreas Lundin, Yvonne Forsell, Catharina Lavebratt, Philippe A Mela. Functional Variation in the Genes. vol 14. issue 9. 2023-09-28. PMID:37761966. |
functional variation in the fatty acid amide hydrolase (faah) is an enzyme that degrades anandamide, an endocannabinoid that modulates mesolimbic dopamine release and, consequently, influences states of well-being. |
2023-09-28 |
2023-10-07 |
Not clear |
| Brittany J Richardson, John Hamilton, Nicole Roeder, Kyriaki Z Thanos, Matthew Marion, Panayotis K Thano. Fatty acid-binding protein 5 differentially impacts dopamine signaling independent of sex and environment. Addiction neuroscience. vol 8. 2023-09-04. PMID:37664218. |
epidermal/brain fatty acid-binding protein 5 (fabp5) plays an integral role in the intracellular trafficking of bioactive lipids/endocannabinoids and the subsequent initiation of cellular cascades affecting cannabinoid and dopamine (da) systems. |
2023-09-04 |
2023-09-07 |
mouse |
| Dora Steel, Kimberley M Reid, Antonio Pisani, Ellen J Hess, Susan Fox, Manju A Kuria. Advances in targeting neurotransmitter systems in dystonia. International review of neurobiology. vol 169. 2023-07-23. PMID:37482394. |
in this chapter we discuss the physiology of key neurotransmitters, including dopamine, noradrenaline, serotonin (5-hydroxytryptamine), acetylcholine, gaba, glutamate, adenosine and cannabinoids, and their role in dystonia. |
2023-07-23 |
2023-08-14 |
Not clear |
| Sam Z Bacharach, David A Martin, Cassie A Stapf, Fangmiao Sun, Yulong Li, Joseph F Cheer, Donna J Cal. Decreased ventral tegmental area CB1R signaling reduces sign-tracking and shifts cue-outcome dynamics in rat nucleus accumbens. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2023-05-19. PMID:37208179. |
here, we examine a critical regulator of the dopamine system; endocannabinoids, which bind the cannabinoid receptor-1 (cb1r) in the ventral tegmental area (vta) to control cue-evoked striatal dopamine levels. |
2023-05-19 |
2023-08-14 |
rat |
| Berhanu Geresu Kibret, Aaliyah Roberts, Adam Kneebone, Shymaa Embaby, Justin Fernandez, Qing-Rong Liu, Emmanuel S Onaiv. Cannabinoid CB2 receptors modulate alcohol induced behavior, and neuro-immune dysregulation in mice. Behavioural brain research. 2023-04-15. PMID:37061199. |
we investigated the role of cannabinoid type 2 receptors (cb2rs) in modulating behavioral and neuro-immune changes induced by alcohol using conditional knockout (cko) mice with selective deletion of cb2rs in dopamine neurons (dat-cnr2) and in microglia (cx3cr1-cnr2) cko mice. |
2023-04-15 |
2023-08-14 |
mouse |
| Berhanu Geresu Kibret, Ana Canseco-Alba, Emmanuel S Onaivi, Ephrem Engidawor. Crosstalk between the endocannabinoid and mid-brain dopaminergic systems: Implication in dopamine dysregulation. Frontiers in behavioral neuroscience. vol 17. 2023-04-03. PMID:37009000. |
crosstalk between the endocannabinoid and mid-brain dopaminergic systems: implication in dopamine dysregulation. |
2023-04-03 |
2023-08-14 |
Not clear |
| Camilla P Dias-Rocha, Julia C B Costa, Yamara S Oliveira, Larissa B Fassarella, Juliana Woyames, Georgia C Atella, Gustavo R C Santos, Henrique M G Pereira, Carmen C Pazos-Moura, Mariana M Almeida, Isis H Trevenzol. Maternal high-fat diet decreases milk endocannabinoids with sex-specific changes in the cannabinoid and dopamine signaling and food preference in rat offspring. Frontiers in endocrinology. vol 14. 2023-03-17. PMID:36926037. |
maternal high-fat diet decreases milk endocannabinoids with sex-specific changes in the cannabinoid and dopamine signaling and food preference in rat offspring. |
2023-03-17 |
2023-08-14 |
rat |